Stability indicating RP-LC-PDA method for the quantitative analysis of saxagliptin in pharmaceutical dosage form
AUTOR(ES)
Scheeren, Laís Engroff, Marcolino, Ana Isa Pedroso, Adams, Andréa Inês Horn, Rolim, Clarice Madalena Bueno
FONTE
Braz. J. Pharm. Sci.
DATA DE PUBLICAÇÃO
2015-06
RESUMO
A saxagliptina é uma inibidora potente e seletiva da enzima dipeptidil peptidase 4. É efetiva no tratamento do Diabete
ASSUNTO(S)
saxagliptina/comprimidos/controle de qualidade cromatografia líquida de alta eficiência/análise quantitativa
Documentos Relacionados
- Stability-indicating RP-LC method for quantification of fusidic acid in cream
- Stability-indicating RP-HPLC method for simultaneous estimation of levosalbutamol sulfate and theophylline in combined dosage form
- Stability indicating RP-HPLC method development and validation of cefepime and amikacin in pure and pharmaceutical dosage forms
- Stability-indicating HPLC determination of pramipexole dihydrochloride in bulk drug and pharmaceutical dosage form
- Application of quality by design approach in RP-HPLC method development for simultaneous estimation of saxagliptin and dapagliflozin in tablet dosage form